THIS MESSAGE (MATERIAL) IS CREATED AND (OR) DISTRIBUTED BY A FOREIGN MASS MEDIA PERFORMING THE FUNCTIONS OF A FOREIGN AGENT AND (OR) A RUSSIAN LEGAL ENTITY PERFORMING THE FUNCTIONS OF A FOREIGN AGENT.
The Ministry of Health of the Russian Federation has registered the world’s first nasal vaccine against COVID-19. According to the press service of the Ministry of Health, the new type of vaccine consists of two doses and is administered at intervals of three weeks.
The vaccine is approved for persons aged 18 years and over. Like Sputnik V, the vaccine consists of two components based on adenoviral vectors of the twenty-sixth and fifth types. It is introduced into the nasal cavity using a special spray nozzle.
The Ministry of Health reported that the vaccine forms mucosal immunity against coronavirus infection on the surface of the respiratory tract mucosa, as well as humoral and cellular immunity in the blood.
Earlier it was reported that Alexander Gintsburg, director of the Gamaleya Research Center for Epidemiology and Microbiology, said that research on the Sputnik M coronavirus vaccine for children aged 6-11 would begin in Moscow at the end of next week.
According to the latest data, in Russia, coronavirus was confirmed in 19,277 people per day. The total number of cases since the beginning of the pandemic is 17 million 842 thousand 925. 3 thousand 855 people were hospitalized per day, which is 10.3% less than the day before. 50,496 people recovered per day, 51,085 a day earlier, 16,838,787 for the pandemic. 345 people died per day, 352 a day earlier, 368,722 since the beginning of the spread of coronavirus.
Source: Rosbalt
Tristin is an accomplished author and journalist, known for his in-depth and engaging writing on sports. He currently works as a writer at 247 News Agency, where he has established himself as a respected voice in the sports industry.
